Choroidal neovascularization usually requires monthly injections, and after three consecutive months of injections, the choice of whether to continue the injections will be based on the results of the examination. Choroidal neovascularization can be treated with intravitreal injections of anti-VEGF medications. The frequency and number of injections need to be determined under the supervision of a doctor, depending on the intraocular pressure, visual acuity, thickness of the macula, and the disappearance of neovascularization. The drugs used for injection include Ranibizumab injection, Bevacizumab injection and Compazine injection, etc. These drugs can inhibit the formation of neovascularization and promote the decline of formed neovascularization, which has a better therapeutic effect on choroidal neovascularization. Patients need to actively cooperate with the doctor’s treatment and review their condition regularly.